- Home
- /
- Treatment
- /
- Page 61
Treatments
The following database contains products that have been granted orphan status, or have been market approval in the EU or the USA.
You can filter the content by clicking on the titles: Product, Indication, Sponsor and Date. Clicking once, will filter the column alphabetically from A – Z and a second click on the same title will filter from Z – A.
Become a Partner.
Country | Product | Indication | Sponsor | Date |
---|---|---|---|---|
N-(2-((4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenamido)ethyl)-2-hydroxybenzamide | Duchenne muscular dystrophy | Catabasis Pharmaceuticals, Inc.;One Kendall Square, Suite B14202, Suite B14202;Cambridge, Massachusetts, 02139 | November 17, 2014 | |
N-(9-methoxynonyl)-1-deoxynojirimycin hydrochloride | Acute dengue illness (inclusive of acute dengue illness, dengue fever, dengue hemorrhagic fever, and dengue shock syndrome) | Emergent Virology, LLC;400 Professional Drive;Gaithersburg, Maryland, 20879 | November 17, 2014 | |
Edasalonexent | Duchenne muscular dystrophy | Catabasis Pharmaceuticals, Inc.;One Kendall Square, Suite B14202, Suite B14202;Cambridge, Massachusetts, 02139 | November 17, 2014 | |
Antagonist of the complement 5a receptor | Atypical hemolytic uremic syndrome | ChemoCentryx, Inc.;850 Maude Avenue;Mountain View, California, 94043 | November 17, 2014 | |
Autologous CD3+ T cells transduced with retroviral vector containing a chimeric antigen receptor directed against CD19 (Autologous CD3+ T cells containing CD19 chimeric antigen receptor) | Acute lymphoblastic leukemia | Juno Therapeutics, Inc.;307 Westlake Ave. N., St. 300;Seattle, Washington, 98109 | November 13, 2014 | |
(S)-perillyl alcohol temozolomide | Glioma | NeOnc Technologies, Inc.;8335 Sunset Blvd., #240;Los Angeles, California, 90069 | November 12, 2014 | |
Autologous CD4+/CD8+ T cells transduced with lentiviral vector containing a chimeric antigen receptor directed against CD19 | Acute lymphoblastic leukemia | Juno Therapeutics, Inc.;307 Westlake Avenue, North, Suite 300;Seattle, Washington, 98109 | November 6, 2014 | |
D6-tetrabenazine, deutetrabenazine | Huntington disease | Teva Branded Pharmaceutical Products R&D;, Inc.;3333 N. Torrey Pines Court, Suite 400;La Jolla, California, 92037 | November 5, 2014 | |
Adeno-associated viral vector serotype 2 containing the human Rab escort protein 1 gene | Choroideremia | NightstaRx Ltd.;215 Euston Road, NW1 2BE;London | November 5, 2014 | |
(S)-1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine | Acute myeloid leukemia | BerGenBio AS;Jonas Lies vei 91, N-5021 Bergen; | November 5, 2014 | |
Clenbuterol | Pompe disease | Duke University Medical Center;Box 103856;Durham, North Carolina, 27710 | October 27, 2014 | |
Alpha-1 proteinase inhibitor (human) | Graft Versus Host Disease | Kamada Ltd.;2 Holtsman Street;Rehovot | October 23, 2014 | |
Bi-shRNA furin and GMCSF Autologous Tumor Cell Vaccine | Ewing's sarcoma | Gradalis, Inc.;2545 Golden Bear Drive, Suite 110;Carrollton, Texas, 75006 | October 22, 2014 | |
Autologous adipose derived mesenchymal stromal cells | Amyotrophic lateral sclerosis | Mayo Clinic;200 First Street SW;Rochester, Minnesota, 55905 | October 22, 2014 | |
Istiratumab | Pancreatic Cancer | Merrimack Pharmaceuticals, Inc.;1 Kendall Square, Suite B7201;Cambridge, Massachusetts, 02139 | October 22, 2014 | |
N-(4-{3-(2-aminopyrimidin-4-yl)pyridin-2-yl]oxy}phenyl)-4-(4-methylthiophen-2-yl)phthalazin-1-amine bis-mesylate dihydrate | Ovarian cancer | Amgen, Inc.;One Amgen Center Drive, Mail Stop 17-2-B;Thousand Oaks, California, 91320 | October 21, 2014 | |
Autologous bone marrow CD34+ cells transduced ex vivo with a self activating HIV-1 -based lentiviral vector, EFS-ADA | Severe combined immunodeficiency | Donald B. Kohn, MD - Professor, UC-UCLA;Microbiology, Immunology & Molecular Genetics, 610 Charles E. Yound Drive, East;Los Angeles, California, 90095 | October 21, 2014 | |
Dabrafenib | Non-small cell lung cancer | Novartis Pharmaceuticals Corporation;1 Health Plaza;East Hanover, New Jersey, 07936 | October 20, 2014 | |
Alteplase | Plastic bronchitis | Kathleen A Stringer, PharmD, FCCP - Professor;University of MI, 428 Church St.;Ann Arbor, Michigan, 48109 | October 20, 2014 | |
[5-Amino-1-(4-fluoro-phenyl)-1H-pyrazol-4-yl]-[3-(2,3-dihydroxy-propoxy)-phenyl]-methanone | Pancreatic Cancer | Synovo GmbH;Paul-Ehrlich-Str. 15, D-72076 Tubingen; | October 20, 2014 | |
Cardiotrophin-1 | Prevention of ischemia-reperfusion injury in kidney transplant recipients | Digna Biotech, S.L.;Avenida Pio XII 22, Pamplona (Navarra); | October 16, 2014 | |
N-(3,4-dihydroxyphenyl)-3,4-dihydroxybenzamide | AL Amyloidosis | ProtaMed, Inc.;14241 Woodinville Duvall Road, Suite # 370;Woodinville, Washington, 98072 | October 15, 2014 | |
Immunoglobulin G1, anti-(human tumour-associated calcium signal transducer 2)(human-Mus musculus monoclonal hRS7 heavy chain), disulfide with human-Mus musculus monoclonal hRS7 k-chain, dimer, hexakis(thioether) with (4S)-4-[[[[4-[[(2S)-2-(4-aminobutyl)-2-[[2-[2-[[26-[4-[[[[4-[(3-mercapto-2,5-dioxo-1-pyrrolidinyl)methyl]cyclohexyl]carbonyl]amino]methyl]-1H-1,2,3-triazol-1-yl]-3,6,9,12,15,18,21,24-octaoxahexacos-1-yl]amino]-2-oxoethoxy]acetyl]amino]-1-oxoethyl]amino]phenyl]methoxy]carbonyl]oxy]-4,11-diethyl-9-hydroxy-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione | Pancreatic Cancer | Immunomedics GmbH | October 15, 2014 | |
N-Methanocarbathymidine | Neonatal herpes | N & N Pharmaceuticals, Inc.;2400 Research Blvd, Suite 310;Rockville, Maryland, 20850 | October 15, 2014 | |
Diacerein | Dystrophic epidermolysis bullosa | Castle Creek Pharmaceuticals;1033 Skokie Blvd, Suite 600;Northbrook, Illinois, 60062 | October 15, 2014 |